PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy
Oncotarget (2015) - Comment
pubmed: 25426562  doi: 10.18632/oncotarget.2803  issn: 1949-2553 

Jian Chen, Huijun Lu, Dongwang Yan, Feifei Cui, Xiaoliang Wang, Fudong Yu, Yingming Xue, Xiaodong Feng, Jingtao Wang, Xiao Wang, Tao Jiang, Meng Zhang, Senlin Zhao, Yang Yu, Huamei Tang, Zhihai Peng